Skip to main navigation
Careers
Contact
News
About
Product Pipeline
XEN1101 (FOS)
XEN1101 (PGTCS)
XEN1101 (MDD)
NBI-921352 (NEUROCRINE)
Investors
Header investor menu
Investor Overview
Stock Quote
stock chart
Historic stock lookup
News & Events
Press Releases
Event Calendar
Corporate Governance
Management
BOARD OF DIRECTORS
Committee Composition
FINANCIALS & FILINGS
ANNUAL FINANCIAL REPORTS
Quarterly Results
contact investor relations
Partners
Medical Affairs
Conferences
Publications
Expanded Access Program
About
Product Pipeline
Investors
Partners
Medical Affairs
Careers
Contact
News
Event Details
Xenon Provides Corporate Update / Overview of Presentations at the 2018 American Epilepsy Society (AES) Annual Meeting
December 3, 2018 at 9:00 AM EST
Supporting Materials
Pre-clinical Poster (Dube) from 2018 American Epilepsy Society (AES) Meeting
330.1 KB
Pre-clinical Poster (Cohen) from 2018 American Epilepsy Society (AES) Meeting
902.7 KB
Pre-clinical Poster (Johnson) from 2018 American Epilepsy Society (AES) Meeting
632.9 KB
XEN901 Poster (Namdari) from 2018 American Epilepsy Society (AES) Meeting
983.1 KB
XEN1101 Poster (Beatch) from 2018 American Epilepsy Society (AES) Meeting
675.3 KB
XEN1101 Poster (Aycardi) from 2018 American Epilepsy Society (AES) Meeting
893.2 KB
Xenon Announces Final Results of XEN1101 Phase 1 Clinical Trial and Update on XEN901 Phase 1 Clinical Trial at the American Epilepsy Society (AES) Annual Meeting
Webcast Presentation
Event Details
Title
Xenon Provides Corporate Update / Overview of Presentations at the 2018 American Epilepsy Society (AES) Annual Meeting
Date / Time
December 3, 2018 at 9:00 AM EST
Investor Relations
investor overview
stock quote
stock chart
historic stock lookup
Analyst Coverage
news & events
press releases
events calendar
Corporate Governance
Management
Board of Directors
Committee Composition
financials & filings
annual financial reports
Quarterly Results
contact investor relations
Tools
print page
RSS Feeds
e-mail alerts